You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 16, 2025

Drug Price Trends for BURN RELIEF


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for BURN RELIEF

Average Pharmacy Cost for BURN RELIEF

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
BURN RELIEF 0.5% SPRAY 70000-0624-01 0.02768 GM 2025-01-22
BURN RELIEF 0.5% SPRAY 70000-0037-01 0.02788 GM 2025-01-22
BURN RELIEF 0.5% SPRAY 46122-0555-28 0.02788 GM 2025-01-22
BURN RELIEF 0.5% SPRAY 70000-0037-01 0.02792 GM 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Burn Relief Treatments

Introduction to Burn Relief Market

The market for burn relief treatments is a significant segment of the healthcare industry, driven by the increasing prevalence of burn injuries globally. This market encompasses a variety of products and services, including wound dressings, topical agents, pain management products, and reconstructive surgery products.

Current Market Size and Growth Projections

As of 2023, the global burn treatment market is valued at approximately US$ 1.2 billion and is projected to grow to US$ 2.59 billion by 2033, with a Compound Annual Growth Rate (CAGR) of 8% during this period[1].

Regional Market Dynamics

Asia Pacific

The Asia Pacific region is expected to exhibit significant growth, driven by increased awareness, substantial increases in healthcare spending, and a rising frequency of burn treatments. India, in particular, is anticipated to dominate the market due to its large population and easy access to burn treatment products. The high population density and the need for advanced healthcare facilities make India a lucrative market for burn treatment products[1].

North America

North America is forecasted to hold a substantial market share, with the United States leading the regional market. The region's growth is attributed to the rising prevalence of burn injuries, government initiatives, and an increase in research partnerships. According to the American Burn Association, over 300 children are treated in emergency rooms each day in the United States, highlighting the high demand for burn treatment products[1].

Drivers of Market Growth

Increasing Prevalence of Burn Injuries

Burns are a global public health problem, with the World Health Organization (WHO) reporting approximately 180,000 deaths annually due to burns. The majority of these deaths occur in low- and middle-income countries, particularly in the WHO African and South-East Asia regions. This increasing prevalence is a key driver of the market growth[1][4].

Technological Advancements

Technological innovations, such as advanced wound dressings and biologics like skin grafts, are crucial in improving patient outcomes and fueling market expansion. These advancements enhance the effectiveness of burn treatments, leading to higher demand and market growth[3].

Government Initiatives and Awareness

Government organizations and private agencies, including the WHO and pharmaceutical companies, are increasing awareness of burn treatments. This heightened awareness contributes significantly to the market's growth trajectory[1].

Market Segments

Burn Ointments

The burn ointment market, a subset of the broader burn treatment market, was valued at USD 1 billion in 2023 and is expected to grow at a CAGR of 5.9% between 2024 and 2032. The increasing incidence of burns, both accidental and industrial, drives the demand for burn ointments[4].

Wound Dressings and Topical Agents

Advanced wound dressings and topical agents are key segments of the burn treatment market. These products are essential for the management and treatment of burn injuries, contributing significantly to the overall market growth[1][3].

Price Projections and Cost Factors

Drug Price Inflation

The overall pharmaceutical market, including burn treatment products, is expected to face drug price inflation. According to Vizient, the overall drug price inflation rate for pharmaceuticals is projected to be 3.81% in 2025. This inflation is partly due to expanding indications of previously approved medications and the introduction of high-cost cell and gene therapies[2].

Patient Treatment Costs

Patient treatment costs, including those for burn injuries, are expected to rise by 7% in 2024, driven by general inflation and increases in pharmaceutical prices. However, the impact of biosimilars and the shift to outpatient care settings may help offset some of these cost increases[5].

Impact of Inflation and Cost Pressures

The rising costs of healthcare, including labor costs and pharmaceutical prices, will continue to influence the burn treatment market. Health care institutions will seek higher reimbursement rates to manage these increased costs, which could affect the pricing and accessibility of burn relief treatments[5].

Technological Innovations and Their Impact on Pricing

Technological advancements in burn care, such as advanced wound dressings and biologics, while improving patient outcomes, can also drive up costs. However, these innovations are crucial for market growth and are expected to continue shaping the landscape of burn relief treatments[3].

Key Takeaways

  • The global burn treatment market is projected to grow from US$ 1.2 billion in 2023 to US$ 2.59 billion by 2033, with a CAGR of 8%.
  • The Asia Pacific region, particularly India, is expected to exhibit significant growth due to increased awareness and healthcare spending.
  • North America, led by the United States, will also see substantial growth driven by the rising prevalence of burn injuries and government initiatives.
  • Technological advancements and increasing awareness are key drivers of market growth.
  • Drug price inflation and overall healthcare cost increases will impact the pricing of burn relief treatments.

FAQs

  1. What is the projected market value of the burn treatment market by 2033?

    • The global burn treatment market is expected to accumulate a market value of US$ 2.59 billion by 2033[1].
  2. Which region is expected to dominate the burn treatment market?

    • The Asia Pacific region, particularly India, is anticipated to dominate the market due to its large population and increased healthcare spending[1].
  3. What are the key drivers of the burn treatment market growth?

    • The increasing prevalence of burn injuries, technological advancements, and government initiatives are key drivers of the market growth[1][3][4].
  4. How does drug price inflation affect the burn treatment market?

    • Drug price inflation, projected at 3.81% in 2025, can increase the costs of burn treatment products, although the impact may be offset by the use of biosimilars and outpatient care settings[2][5].
  5. What role do technological innovations play in the burn treatment market?

    • Technological innovations, such as advanced wound dressings and biologics, improve patient outcomes and drive market growth, despite potentially increasing costs[3].

Sources

  1. Future Market Insights, "Burns Treatment Market - Size, Growth, Trends, Share | 2033"
  2. Vizient, Inc., "Vizient projects drug price inflation at 3.81%"
  3. Market.US, "Burn Care Market Forecast US$ 6.17 Billion By 2033"
  4. Global Market Insights, "Burn Ointment Market Size & Share Report, 2024 – 2032"
  5. Drug Topics, "Patient Treatment Costs to rise 7% in 2024, Report Finds - Drug Topics"

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.